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The antimicrobial resistance (AMR) crisis is the increasing global incidence of infectious
diseases affecting the human population, which are untreatable with any known antimi-
crobial agent.This crisis will have a devastating cost on human society as both debilitating
and lethal diseases increase in frequency and scope. Three major factors determine this
crisis: (1) the increasing frequency of AMR phenotypes among microbes is an evolutionary
response to the widespread use of antimicrobials; (2) the large and globally connected
human population allows pathogens in any environment access to all of humanity; and (3)
the extensive and often unnecessary use of antimicrobials by humanity provides the strong
selective pressure that is driving the evolutionary response in the microbial world. Of these
factors, the size of the human population is least amenable to rapid change. In contrast,
the remaining two factors may be affected, so offering a means of managing the crisis: the
rate at which AMR, as well as virulence factors evolve in microbial world may be slowed by
reducing the applied selective pressure. This may be accomplished by radically reducing
the global use of current and prospective antimicrobials. Current management measures to
legislate the use of antimicrobials and to educate the healthcare world in the issues, while
useful, have not comprehensively addressed the problem of achieving an overall reduction
in the human use of antimicrobials. We propose that in addition to current measures and
increased research into new antimicrobials and diagnostics, a comprehensive education
program will be required to change the public paradigm of antimicrobial usage from that of
a first line treatment to that of a last resort when all other therapeutic options have failed.
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INTRODUCTION
The microbial world, being the sum of all of those organisms that
are too small to be discerned with the human eye, is diverse, abun-
dant, and ubiquitous. Containing not only bacteria and viruses
but also vast numbers of many different types of multicellular
organisms (1, 2), the microbial world is also the basis of the global
ecology. These apparently invisible organisms inhabit all ecological
niches on this planet, including every surface, cavity, and cellular
milieu of every human. The majority of these microbial “passen-
gers” are largely benign or even beneficial to their human hosts
through their interactions with the wider ecology. However, some
few are active predators, causing damage, morbidity, and even
lethal outcomes. The gross effect of these pathogens is infectious
disease. While a small proportion of the overall microbial diver-
sity, pathogens are nevertheless numerous and diverse and have
evolved many ways of both reaching and then taking advantage of
the biological resource represented by their human prey.
In order to combat infectious disease, a suite of chemicals
known as antimicrobial agents that are effective in limiting, pre-
venting, or eliminating the growth of microbial predators has
been developed. The majority of these antimicrobials originated
in natural products where they were originally used by various
organisms to defend against microbial attack (3, 4). Having been
isolated and characterized, many of these “natural” products have
been subsequently modified by humanity to create additional or
amplified antimicrobial activity (3). The actions of many of these
antimicrobial agents are specific to particular types of pathogen
though others may affect broad ranges of microbes. These antimi-
crobial agents include antiseptics, antibiotics, antifungals, and
anti-helminthics, as well as many others targeted against other
specific types of pathogen.
The administration of antimicrobials in the treatment and
prevention of infectious disease has provoked an evolutionary
response among microbes by producing resistance to the applied
antimicrobial (5). A graphic example of this is the widespread
evolution of antibiotic resistance since the general introduction of
penicillin during World War 2. While initially effective against a
wide range of bacterial diseases, today, <70 years later, there are
increasing numbers of pathogens that are not only resistant to
penicillin and its derivatives but also to all other available antibi-
otics (6). Similarly, many other non-bacterial pathogens such as
the causative organism of malaria, Plasmodium spp, are now also
becoming resistant to all known antimalarial treatments (7). This
evolution of resistance in the microbial world is an evolutionary
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response to the widespread and indiscriminate use of antimicro-
bials. Combined with the increasingly large and connected human
population upon the Earth, prevalent antimicrobial resistance
(AMR) will see the rise of not only debilitating but also poten-
tially lethal epidemics for which there is no effective treatment.
Such epidemics may be global in extent and ongoing in tenure,
and so represent the urgent consequences of the current AMR
crisis (8).
In this work, we shall review the causes of the AMR crisis and
the current and developmental measures to address it. We also
address the likelihood that no solution to this crisis will be defini-
tive, and that continual management of this issue will be required
across human society. Finally, we shall propose actions additional
to those already being taken to assist in addressing and managing
this crisis.
CONSEQUENCES OF THE AMR CRISIS TO HUMAN SOCIETY
In 2013, the Centers for Disease Control (CDC) in the USA
asserted that the human race is now in the“post-antibiotic”era (9).
In May 2014, the World Health Organization (WHO) stated that
the AMR crisis is becoming dire (8). The rise of AMR in current
human society will mean that on an individual level, an increas-
ing use of older less effective techniques in controlling infections
will be required. Such techniques, including debridement, disin-
fection, amputation, and isolation will mean that the process of
treating infections will take longer, be far more invasive, and will
be less successful. While the prospect of global pandemics such
as the Spanish Flu of 1918 with their attendant horrendous death
tolls are not unlikely, non-lethal illnesses will also extend to more
people, more often, and will take longer to resolve. This increasing
incidence of debilitating and lethal disease will have a significant
effect on human society.
While disease has always been a feature of human society, its
probable future impact on a large and increasing human pop-
ulation without the benefit of effective antimicrobials is varied
and significant. The economic impact of increasing numbers of
untreatable infectious diseases will become significant, as larger
numbers of productive individuals are lost from the workforce for
increasing periods of time (10, 11). Additionally, the increasing
burden of caring for those suffering will place additional loads on
their families and community, as well as the wider health care sys-
tems. The flow-on effects of this loss of labor and increased load
on health services will reduce the national outputs of most coun-
tries compared to current levels and will have rippling societal and
cultural impacts. In addition to these cumulative effects caused
by increasing morbidity, the potential impacts of untreatable, vir-
ulent, and lethal pandemics would at least equal the impact of
the global Spanish flu epidemic of 1918 where at least 50 million
people died (12).
WHY IS THERE AN AMR CRISIS NOW?
Infectious disease is an example of predation by microbial organ-
isms upon macroscopic organisms and has been a feature of the
ecology of the planet for eons. Epidemics such the bubonic plague,
influenza, and many others have been present throughout history,
and yet our current situation is a crisis threatening the ongoing
health of humanity that surpasses any previous threat by infectious
disease. That this crisis has come to a turning point now is the
inevitable co-incidence of a number of factors within the ecology
of the planet and humanity’s place within it.
MICROBIAL CAUSES
The microbial world includes organisms whose direct ancestors
were present at the beginnings of life on this planet approximately
3.5 billion years ago. As well as having a long heritage of survival
on the Earth, microbes today are both abundant and diverse, with
over 10 billion (10e7) individuals, typically of thousands of dif-
ferent types, present in a typical gram of soil (1, 2). The success
of microbial life and hence larger life on this planet can be linked
directly to the microbial ability to rapidly and effectively adapt
to environmental change (13, 14). Increasingly, we are becoming
aware of the diverse and persistent mechanisms that facilitate this
microbial resilience.
Due to their small size, microbes are necessarily simple when
compared with large multicellular organisms like humans. This
simplicity is reflected in their relatively small complement of
genetic material (genome). These small genomes and the indi-
vidual microbes that carry them cannot each contain the wide
variety of accessory genes that might be required to address ever-
varying environmental challenges. So, microbes as individuals are
limited in their ability to cope with environmental challenges.
However, when considered as communities, microbial populations
are remarkably protean in their ability to adapt both quickly and
effectively. The key to this adaptive strength, lies in the huge num-
bers of individual microbes present in small volumes, and their
rapid generation time, which may be as little as 20 min in the
common enteric bacterium Escherichia coli. Thus, while random
change within a single genome may be rare, the vast microbial
numbers present in every environment ensures that variations
within populations will occur often and locally. Similarly, the
rapid generation time of most microbes ensures that advantageous
changes will rapidly become prevalent in the continually growing
and evolving microbial community.
One source of genetic variability is mutation. Mutation is the
random change in the genetic sequence of an organism and gen-
erally has either no effect on the organism or else is deleterious.
However, when immense numbers of organisms are involved, the
chance of a rare advantageous change arising becomes inevitable.
While mutation produces new responses to adaptive challenges,
microbial “solutions” to past adaptive challenges have also not
been lost. A second source of microbial variability is available in
large “reservoirs” of adaptive genes that may be “mobilized” within
and between microbial species (13, 15, 16). These mobile adaptive
genes are available to entire microbial communities through the
varied mechanisms of horizontal gene transfer (HGT). Among
those mobile genes that have been so far characterized, many have
been shown to provide“solutions”to many different adaptive chal-
lenges such as resistance to heavy metals, oxidative stress, UV light,
and antibiotic resistance, as well as providing virulence determi-
nants. These adaptive genes may be mobilized both within and
between “species” in microbial communities undergoing stress
and importantly, it has also been shown that the various mobilizing
mechanisms are themselves responsive to stress and mobilize genes
more frequently in stressed populations (17). The microbial ability
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to create new phenotypes and to transfer both novel phenotypes
and existing adaptive genes between disparate individuals, rapidly
changes the genetic complement and hence, the adaptive ability of
not only individuals but also entire microbial communities.
Antimicrobials are designed to either limit or prevent the
growth of microbes and in so doing create a selective pressure upon
microbial communities. Under antimicrobial treatment only those
microbes able to survive and reproduce will predominate within
the microbial community, so causing their “advantage” to become
common. More aggressive and persistent use of antimicrobials
increases the selective pressure on the microbial community to
which they are applied, generating more adaptive solutions to the
applied stress, faster. The widespread and intense application of
antimicrobials by humans provides a strong and polarized selective
pressure that will continue to provoke a strong adaptive response
in the microbial world.
The depth of microbial history, combined with the demon-
strated ability of the microbial world to adapt to even many
synthetic compounds suggests that resistance to future antimi-
crobial strategies is also likely. Consequently, it is likely that the
current AMR crisis will not be resolved by a single new product
or therapy. However, because the rate at which AMR evolves may
be related to the strength of the applied selective pressure, the use-
ful life of existing and prospective therapies may be extended, by
significantly moderating the use of both current and forthcom-
ing antimicrobials (18). Accordingly, the rate at which microbial
adaptation to antimicrobials occurs is amenable to moderation.
HUMAN CAUSES
Human population
According to the United Nations Population Fund (19), there are
currently approximately seven billion people upon the Earth and
in the surrounding space. The human population passed six bil-
lion people in 1999 and is expected to reach eight billion in only a
few more years’ time if there is no significant impediment to our
growth. Such increases, when graphed across time show the expo-
nential growth that is seen in any organism living in a relatively
accommodating environment with abundant resources. Classi-
cally seen in bacterial cultures, such growth continues until either
resources are exhausted and mass starvation ensues or else the
population is limited by other factors.
In addition to the rapidly increasing numbers of humans, we
also show a marked propensity for gregarious behavior living
in closely associated groups ranging from tens of individuals to
many millions. The urbanization of human populations has been
a dynamic process that passed a significant milestone in human
history early in the twenty-first century. In the year 2007, for the
first time more than half the world’s population resided in urban
centers (20). Such large numbers of people living in close prox-
imity provides significant opportunity for the rapid proliferation
of infectious disease. The need to support such groupings of peo-
ple requires that agricultural systems are both large and intensive
in nature and often in close proximity to population centers, so
ensuring additional close links of large groups of humans with the
wider biosphere.
In addition to increasing urbanization and increased total pop-
ulation, global humanity is now effectively a single biological
population. Individuals may travel to most places on the planet
within 1 or 2 days, and may realistically access any other human
population and indeed virtually any environment on the planet
within a week. This means, firstly, that along with the ability to
rapidly transport humans, their attendant microbes and pathogens
may also cross the planet rapidly and without significant impedi-
ment. Such rapid travel can transport infected individuals across
the planet many times before even the first symptoms of infections
become apparent, so allowing pathogens to be distributed globally.
The second implication of humanity’s large and effectively con-
tiguous population is that the entire human population is now
exposed to both potential and existing pathogens from all envi-
ronments that humanity comes in contact with. This means that
not only are a much broader range of microbial predators given
access to human populations but also that those successful preda-
tors will have a much larger biological resource to exploit. In short,
humanity now presents a large and accessible target for microbial
predators across the planet (8).
Overuse of antimicrobials
When introduced, antimicrobials were a “silver bullet,” capable of
rapidly, and specifically treating infectious disease without undue
deleterious side effect upon the patient. This remarkable effective-
ness lead to their widespread usage, and a persistent belief among
the general public that antimicrobials are universally efficacious
and should therefore be applied in the first instance to virtually
all ailments. The belief in the universal applicability of antimi-
crobials has resulted in their exuberant use and so has applied a
widespread, strong, and polarized selective pressure on the micro-
bial world. This has resulted in the increasing rates of AMR seen
today (21–25). Some of the societal practices that illustrate this
profligate use of antimicrobials are now discussed.
CLINICAL USAGE
Over prescription
The first source of overuse in clinical practice is the empiri-
cal use of antimicrobials by clinicians. This random application
of antimicrobials is largely due to the practical shortcomings in
rapidly and accurately diagnosing infectious disease, its causative
pathogen and perhaps most importantly, the susceptibility of
the pathogen to a particular antimicrobial therapy. Such accu-
rate diagnosis currently requires multiple laboratory-based tests
that can often take days or even weeks to complete. Understand-
ably, the presentation of a patient with life threatening symptoms
requires immediate action. Often, this action takes the form of the
simultaneous administration of many different antimicrobials in
the hope that one will be useful in controlling the unidentified
pathogen. This over-application of antimicrobials usually occurs
in extreme cases in hospital-based patients and so is relatively con-
trolled, though the development and implementation of rapid and
accurate diagnostics would alleviate this problem (26).
Much more widespread than the empirical treatment of acutely
ill patients is the serial application of antimicrobials by general
practitioners (27). This situation arises when a patient presents
to a practitioner with an ailment possibly due to an infectious
pathogen. Rather than always testing for pathogen and antimicro-
bial sensitivity, the practitioner often prescribes an antimicrobial
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therapy based upon past experience and local epidemiology. This
may be effective in reducing the time to cure from initial pre-
sentation given the length of time taken for diagnostic testing
to occur if the practitioner has guessed correctly regarding the
pathogen. However, often the initially prescribed antimicrobial is
not appropriate, so requiring repeated visits and successive courses
of different antimicrobials until an effective treatment is found.
This process not only fails to effect a prompt cure but also sub-
jects the patient’s microbiota to an intense and repeated selective
pressure that encourages and conserves the development of AMR
among currently non-pathogenic organisms. This resistance may
then be transferred via HGT across many microbial communities
and importantly, to previously sensitive pathogenic organisms.
Often, the serial application of antimicrobials is driven by
patient demand for an immediate resolution to their illness (28).
This can take the form of belligerent patients demanding antimi-
crobials at one extreme and at the other, over prescription by
practitioners to appease patients and so garner repeat business.
By lessening the demand for the immediate application of antimi-
crobials in non-acute patients, the use of appropriate diagnostics
will be facilitated and so effective and appropriate prescription of
antimicrobials will occur more frequently.
Entrenched methodologies
Prescribed antimicrobials are generally applied in a fixed regi-
men, dictating the dose, rate, and period. Typically, such regimens
last 5–7 days, though many have now been extended to 14 days or
even longer. The fundamental assumption behind such extended
regimes is that high dosages over long periods will eradicate the
infecting pathogen from the body. However, recent studies demon-
strate that the rates of relapse are not significantly higher in
patients where the treatment regime ceases as symptoms dimin-
ish, as compared to those taking the full course of treatment (29,
30). By limiting courses of treatment to the minimum dose and
period required to achieve a clinical result, the selective pressure
on “non-combatant” organisms within the patient and the wider
environment will be limited, and hence so will the speed of the
overall microbial adaptive response.
PUBLIC PERCEPTION AND BEHAVIOR
The perception by the lay public of antimicrobials as a quick
and effective antidote to the majority of maladies has generated
behaviors that effectively circumvent the control of a prescribing
physician (31).
Hoarding
The practice of not completing prescribed courses of antimicro-
bial treatment may not materially affect the immediate clinical
outcome to the patient. However, where the balance of the course
is “hoarded” against a perceived future need, the potential for mis-
application of antimicrobial therapy to non-susceptible organisms
is significantly increased.
Non-prescription purchase
Controlled access to antimicrobials is not global. In many coun-
tries, the production and sale of antimicrobials is relatively or
completely unregulated. This results in the production of ther-
apeutic materials of extremely variable quality that are available
to the public cheaply and in large amounts. Before the advent
of the Internet, access of such supplies of antimicrobials to first
world countries was restricted to returning travelers. However,
online shopping has enabled widespread access to even currently
restricted antibiotics such as rifampicin and ciprofloxacin (31).
AGRICULTURAL APPLICATIONS
By treating both stock and crops with antimicrobials, the overall
health of the stock and crops is improved and hence the ultimate
agricultural yield can be significantly increased. The commercial
justification of such measures in producing more and higher qual-
ity product quickly is clear, and can be further justified when large
sections of the human population continue to experience food
insecurity and famine. However, the impact of such a consistent
selective pressure applied to the natural environment through the
gross application of antimicrobials is also clear. The evidence of
increasingly abundant and diverse AMR genes in urban, agricul-
tural, and apparently pristine environments, suggests that these
activities combined with the domestic and clinical use of antimi-
crobials have already had profound effects upon the microbial
ecology (22–25).
COMMERCIAL PRESSURES
In addition to the commercial pressure encouraging the agricul-
tural usage of antimicrobials, an even more concerted campaign
has been directed at the general public. The premise of this cam-
paign is that humans need to be completely and permanently
“clean” at a microscopic level. That is, in order to ensure our con-
tinued health and happiness, our skins, mouths, and guts must be
routinely cleansed of all microbial life. Additionally, other sur-
faces that we may come into contact with such as tables and
floors must also be routinely disinfected. It is true that in some
situations, such as in food preparation and in handling poten-
tially infectious material, precautions against microbial infection
are necessary. However, the general and complete eradication of
microbes from both domestic surfaces and ourselves is neither
necessary nor possible or even beneficial to health. Recent anec-
dotal evidence suggests that the development of a comprehensively
equipped immune system requires exposure to environmental
antigens (32). This exposure develops a cohort of specific anti-
body generating cells that are present throughout life and is also
the basis by which vaccination is effective. Normally, such cellular
cohorts and the immunities they trigger are generated in younger
years and are supplemented with exposure to novel antigens later
in life. By limiting the exposure to environmental antigens through
the over-insistence on“clean”environments the developing suite of
immunities may be limited in both children and adults. As a result,
with the increasing incidence of such compromised immune sys-
tem versatility, less virulent infections are more easily able to cause
morbidity and mortality (33).
Effective and diverse marketing campaigns convince the general
public of the necessity of overarching cleanliness. The profitable
nature of such campaigns has now produced a vast range of
antimicrobial products routinely used in society. These products
now include antimicrobials in everything from floor cleaners to
eye-drops. The diversity of such products in public use contrasts
strikingly with the relatively few effective disinfection methods
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typically used in clinical settings, where reliance on bleach, alcohol,
autoclaving, and a relatively few other strong disinfectants for
surface cleaning have proven sufficient for even such stringent
applications.
VACCINATION RELUCTANCE
Vaccination is the process whereby the human immune system is
exposed to an antigen associated with a known pathogen, without
actual infection by the pathogen. This process produces immune
cells within the patient that subsequently recognize the pathogen
and so provide a rapid immune response should the patient be
exposed later in life. Vaccination programs have been effective in
limiting the incidence of infectious disease. Diseases such as small-
pox and polio have been virtually eliminated from many human
populations, and in the case of smallpox, from the environment as
well (34). However, it is important to note that vaccination is pro-
tective to the vaccinated individual only. Accordingly, in commu-
nities where the incidence of vaccination decreases, un-vaccinated
individuals become increasingly subject to the re-emergence of
diseases previously held at a low level (35). Such re-emergence
leads to an increase in pathogen numbers within the population
that may then more readily infect individuals who are not yet
vaccinated such as small children, or those who are immunocom-
promised such as older people and those otherwise susceptible.
Currently, increasing numbers of people are declining vaccination
for themselves and their children, often for specious reasons (36).
In so doing, they not only endanger themselves and their children
but also create increasing reservoirs of pathogen within society
that may subsequently become antimicrobial resistant.
SUMMARY
The ability of the microbial world to accommodate all existing and
in all likelihood all future antimicrobial therapies, indicates that
there will not be a durable solution to the AMR crisis. Similarly,
the large and increasing human population dictates that increasing
numbers of untreatable infections will have an increasingly delete-
rious effect on both individuals and society. The ongoing nature of
the AMR crisis will therefore require a shift in the general percep-
tion of antimicrobials and their use at all levels of society so that
the effectiveness of both existing and prospective antimicrobials
will be protected and extended for as long as possible. Additionally,
current efforts to research and develop new antimicrobial mate-
rials, therapies, and diagnostics will need to be supported and
extended so as to ensure that novel solutions become available
before older therapies become ineffective.
In order to extend the efficacy of current antimicrobials within
the human population, their use should be minimized wherever
possible. Such restricted usage requires the application only of
antimicrobials to which the infecting pathogen is sensitive, applied
for the minimum amount of time and in the minimum dose
required in order to achieve the desired clinical effect. Further,
the elimination products from the use of antimicrobials should
as far as possible be prevented from entering the wider environ-
ment. To achieve this goal, the continuation of both legislative
and professional control will certainly be required. Additionally,
the education of both the corporate world and the general pub-
lic will be required so as to reduce the demand for antimicrobials
from society (37). This may be facilitated through consultation and
collaboration with relevant stakeholders such as health profession-
als, the general public, agribusiness, pharmaceutical companies,
the media, expert, and legislative bodies.
HOW IS THE CRISIS CURRENTLY BEING HANDLED?
The existence of the antimicrobial crisis and its importance to
the future of the human race is widely acknowledged among peak
health care bodies such as the CDC and the WHO (8,9). Along with
acknowledgment of the problem, these bodies provide a number
of recommendations that have contributed to actions intended
to manage the crisis. These recommendations have resulted in a
series of actions and programs designed to address the AMR crisis.
These activities fall into two main categories: those that address
the prevention of disease so that the need for antimicrobials will
be limited and those that provide new or more efficient treatments
to either augment or supplant existing antimicrobial therapies. In
brief, these measures include disease prevention through the use of
vector control, vaccination, public education, clinical education,
and legislative action is recommended. Rapid and effective disease
management through the use of diagnostics for microbial identi-
fication, microbial sensitivity testing to existing antimicrobials to
determine appropriate therapies are also advocated (8).
All of these initiatives have been useful in improving the
health of their target populations. However, the accelerating inci-
dence of infections resistant to antimicrobial therapy indicates
that these measures should be expanded and additional measures
implemented if resistant microbial infection is to be contained.
DISCUSSION
The factors contributing to the origins of the AMR crisis are
threefold. These are the increasingly large and connected human
population, the protean ability of the microbial world to adapt to
environmental challenges and the profligate overuse of antimicro-
bials by human society. We assume that by modifying any or all of
these factors, the crisis may be ameliorated.
The size, extent, and connectedness of the human popula-
tion are not readily subject to influence. This means, firstly, that
humanity will continue to be exposed to virtually all existing and
presumptive pathogens. Secondly, the entire microbial ecosys-
tem is potentially subject to the antimicrobials used by human
society. Consequently, novel pathogens, arising as zoonoses and
through other means are exposed to the global antimicrobial use,
and so resistance in these new pathogens will also continue to
increase (38).
Importantly, the demonstrated ability of the microbial adaptive
mechanisms to provide effective “answers” to all environmental
challenges encountered over the last 3 billion years indicates that
resistance to current antimicrobials will continue to occur as long
as a strong selective pressure is imposed upon microbial popu-
lations. Additionally, the ability of microbial adaptation to take
advantage of even synthetic materials suggests that resistance to
existing future antimicrobial strategies will also arise. Therefore,
it is likely that there will be no single long-lasting solution to the
problem of resistant infectious disease.
The adaptive ability of microbes provides the necessary flexibil-
ity for the microbial world to cope with environmental change, and
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is in essence the basis of the evolutionary process. The microbial
world is an integral part of the global ecology and so its adaptability
is ultimately of benefit to the global ecology, including human-
ity. For this reason, attempts to directly inhibit the broad suite
of adaptive mechanisms that enable genetic diversity should be
avoided. However, this does not mean that the specific response
of microbes to the use of antimicrobials may not be indirectly
modulated.
It has been demonstrated that many of the microbial adaptive
processes are themselves responsive to the intensity of the selec-
tive challenge (17, 18). Consequently, by reducing the exposure of
the microbial world to antimicrobials the corresponding selective
pressure will be reduced and so will the speed with which AMR
arises and is disseminated within the microbial world. Therefore,
in view of the ongoing nature of the AMR crisis, we suggest that
the management of this crisis will require a twofold approach.
Firstly, the search for new antimicrobial materials, therapies com-
bined with rapid and cost effective diagnostics must be continued
and expanded into the future. Secondly, measures to limit the
exposure of the global microbial community to applied antimi-
crobials should be taken in order to preserve the effectiveness of
current antimicrobial therapies. Both of these strategies can be
accomplished.
The third factor causing the AMR crisis and that of human
behavior causing the extensive use of antimicrobials is also
amenable to change. Currently, educational campaigns regarding
AMR have been implemented among clinicians and their gov-
erning bodies. These campaigns have been effective in raising the
awareness of healthcare professionals to the AMR threat. These
campaigns have resulted in some alteration of prescribing prac-
tices as well as stewardship programs in many countries to restrict
the use of some antimicrobials to that of a last resort treatment in
particular patients (39, 40). Legislative and regulatory mechanisms
have also been emplaced in many countries to restrict and control
the use of some groups of antimicrobials such as antibiotics, with
more groups of antimicrobials under discussion (41).
While these measures represent good governance and have
been effective in advising professional groups and in limiting
the use of specific chemicals in some areas, they have not been
comprehensive in alleviating the overall use of antimicrobials.
Most antimicrobials remain uncontrolled and their use is often
ill advised in light of the current resistance crisis. We propose that
additional measures are required to reduce humanity’s overuse of
antimicrobials.
The current usage of antimicrobials is driven largely by pub-
lic perception of their value. The desire for a healthy life has
been closely linked in the public mind with the absence of all
microbes from both the individual and their proximate environ-
ment. This desire has its roots in broad public health campaigns
that are themselves responsible for increasing levels of hygiene
and consequently decreasing infection rates within society. Unfor-
tunately, these reasonable hygienic practices have been extended
into the unnecessary overuse of antimicrobials. This overuse has
been further encouraged in the general public by the plethora
of antimicrobial containing products now being marketed. The
perceived benefits of such products have caused them to pro-
liferate, so adding significantly to the selective pressure on the
microbial world. Combined with the widespread prophylactic
use of antimicrobials in agriculture, these two areas of antimi-
crobial usage have provided perhaps the most widespread and
intense selective pressure upon the environment (25). Both of
these areas of antimicrobial use, if reduced significantly, could
provide the useful extension in current antimicrobial effectiveness
that is needed until new therapies become available.
Experience shows that attempting to directly legislate or other-
wise control public and corporate activities on health care issues
has proven difficult. Examples include drawn out battles with the
tobacco industry to limit smoking despite overwhelming evidence
of the debilitating effect. Similarly, attempts to moderate the cur-
rent obesity epidemic in the western world, which has its roots in
the large amount of energy-dense foods consumed and often sup-
plied by fast food chains, have also met significant resistance. The
only successes in these and other campaigns have occurred when
public opinion has changed significantly, so making the ruling
legislative and market conditions untenable. Accordingly, we sug-
gest that in order to limit broad antimicrobial usage and thereby
manage the AMR crisis, the first step should be to investigate
stakeholder perceptions about the AMR issue generally in order
to then address and inform the public perception of appropriate
antimicrobial usage (42).
We suggest that the efficacy of all existing measures to address
the AMR crisis will be enhanced if the current perception by
the general public of antimicrobials as a “first line” of prophy-
laxis and treatment for potential pathogens were to become an
appreciation that antimicrobials of all sorts were to be used only
in selected situations and as a “last line” of defense in infec-
tious disease. If such a paradigm shift was achieved, not only
would the selective pressure upon the environment be reduced
but also the public pressure upon clinical services to instantly pro-
vide antimicrobial treatment for ailments would also diminish.
Similarly, the need for ever more assertive legislation would also
decrease. The moderation of the perceived need for absolute steril-
ity in the home and elsewhere would alleviate the attraction for
antimicrobial containing products, and the insistence on maximal
agricultural production through the use of antimicrobials would
also be reduced.
Human attitudes in all cultures and at all scales have been inten-
tionally and successfully altered throughout history and often for
prosaic reasons. The repeated ability of charismatic leaders to sway
entire populations is a case in point. Conversely, many attempts
to sway public opinion have been unsuccessful, with numerous
marketing and political campaigns failing to meet their desired
objectives. In order to systematize this area of endeavor, both the
measurement and analysis of the public perception, as well as in the
more pragmatic area of changing public perception are the subjects
of considerable study (43, 44). Among psychologists, sociologists,
and geographers, the assessment of risk and its impact on human
society involves both the physical factors that might prompt a dan-
gerous situation, and also the perception of people, both singly and
in groups, of the potential of that situation to be“risky.”It has been
found that the dichotomy between “real” and “perceived” risk and
consequently the propensity or otherwise of a population to adopt
behaviors that mitigate risk varies significantly with time, cultural,
socio-economic, and other demographic factors (44, 45).
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Risk perception and risk behavior as a field of enquiry has
evolved rapidly in the last 50 years and has developed a variety
of theoretical and methodological approaches that can be applied
to specific stakeholders to investigate why they hold the views,
attitudes, and perceptions (toward risk) that they do (46). Once
the context for and drivers of risk perception and behaviors are
understood, it becomes possible to develop targeted and effective
education programs aimed at behavioral change (47). These find-
ings have resulted in a variety of empirical methodologies, which,
with appropriate examination of ruling attitudes and their causes,
can lead to a shift in a society’s perception and consequent actions
toward hazardous situations (48–50).
In order to inform and therefore influence public perception
on the appropriate use of antimicrobials, a social awareness pro-
gram that is both diverse and prolonged will be required. Because
of the ongoing nature of the AMR crisis, a single short dura-
tion initiative is unlikely to achieve the permanent shift in public
usage of antimicrobials that is required (39). Additionally, a pro-
gram both sensitive to local attitudes and responsive to changing
cultural environments will need to be implemented. Further, in
order to increase the public understanding of the basic message
of caution in the use of antimicrobials, multiple complimentary
“messages” each reinforcing the basic premise will need to be dis-
seminated. Both primary messages such as “antimicrobials should
only be taken when prescribed by your doctor” and complemen-
tary messages such as “keeping your immune system ready to
combat disease will keep you healthy” will be needed. Such a
program will also necessarily use multiple means of information
delivery ranging from print and televised media through all of the
various electronic media as well as personal contact. Finally, in
order to ensure that the program remains effective, ongoing sam-
pling of societal values with regard to antimicrobial usage will also
necessarily feature.
The objective of permanently changing public perception of
antimicrobial usage is necessary in light of the growing AMR cri-
sis. However, such an initiative will require coordination at local,
national, and global levels to ensure a consistent “message” and
also culturally appropriate local implementation. Perhaps most
importantly, the overall ethical conduct of such a broad based
public information campaign must be regularly scrutinized so that
the impetus of the program is not lost due to intervening loss of
direction or scandal.
The healthcare sector has been largely responsible in most
aspects of public education to date, and clinicians certainly have
an authoritative and personal relationship with most of the com-
munity. However, their generally limited continuous access to the
broader community necessitates the inclusion of additional groups
to promulgate such a broad based change in public attitude. Such
groups might include existing public health organizations such
as NGO’s, governmental agencies such as disaster management
committees, or even the incorporation of dedicated organizations.
However, while such long-term oversights are necessary, the first
steps in implementing such measures can be more immediate and
accessible. We propose that in the first instance,a broad based study
into the current public perception of antimicrobial usage should be
implemented immediately. By considering economic, geographic,
and ethnographic factors in such a study, useful information in
developing a suitable subsequent public education campaign will
arise. Moreover, we propose that such a study should not be limited
to one locality or even one country. In so doing, the starting point
for the following information campaign can be established. Addi-
tionally, by bringing together the expertise of various scientists,
and their disparate disciplines as well as oversight groups, in com-
mencing such a study, a kernel of specialists in the problem having
a common dialog will be created. Such a co-operative multina-
tional approach would yield the basis of a coordinated global
approach to the management of the AMR crisis.
CONCLUSION
The current AMR crisis is likely to be a permanent feature of
human society, causing increased human suffering and attendant
social costs. Managing this crisis so as to limit its effect upon
humanity will require a fundamental shift in the global perception
of antimicrobial usage. We believe that such a shift is certainly
possible and that the first steps in achieving this must be taken as
soon as possible.
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